221 related articles for article (PubMed ID: 19670459)
1. Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis.
Gastaldelli A; Harrison SA; Belfort-Aguilar R; Hardies LJ; Balas B; Schenker S; Cusi K
Hepatology; 2009 Oct; 50(4):1087-93. PubMed ID: 19670459
[TBL] [Abstract][Full Text] [Related]
2. Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review.
Shyangdan D; Clar C; Ghouri N; Henderson R; Gurung T; Preiss D; Sattar N; Fraser A; Waugh N
Health Technol Assess; 2011 Nov; 15(38):1-110. PubMed ID: 22059955
[TBL] [Abstract][Full Text] [Related]
3. Pioglitazone versus vitamin E versus placebo for the treatment of non-diabetic patients with non-alcoholic steatohepatitis: PIVENS trial design.
Chalasani NP; Sanyal AJ; Kowdley KV; Robuck PR; Hoofnagle J; Kleiner DE; Unalp A; Tonascia J;
Contemp Clin Trials; 2009 Jan; 30(1):88-96. PubMed ID: 18804555
[TBL] [Abstract][Full Text] [Related]
4. Clusters of adipose tissue dysfunction in adults with type 2 diabetes identify those with worse lipidomic profile despite similar glycaemic control.
Della Pepa G; Carli F; Sabatini S; Pezzica S; Russo M; Vitale M; Masulli M; Riccardi G; Rivellese AA; Vaccaro O; Bozzetto L; Gastaldelli A
Diabetes Metab Res Rev; 2024 May; 40(4):e3798. PubMed ID: 38558269
[TBL] [Abstract][Full Text] [Related]
5. Glucose Tolerance is Linked to Postprandial Fuel Use Independent of Exercise Dose.
Gilbertson NM; Eichner NZM; Francois M; Gaitán JM; Heiston EM; Weltman A; Malin SK
Med Sci Sports Exerc; 2018 Oct; 50(10):2058-2066. PubMed ID: 29762253
[TBL] [Abstract][Full Text] [Related]
6. Divergent pathways of liver fat accumulation, oxidation, and secretion in lipodystrophy versus obesity-associated NAFLD.
Klein RJ; Viana Rodriguez GM; Rotman Y; Brown RJ
Liver Int; 2023 Dec; 43(12):2692-2700. PubMed ID: 37622286
[TBL] [Abstract][Full Text] [Related]
7. Pentoxifylline decreases oxidized lipid products in nonalcoholic steatohepatitis: new evidence on the potential therapeutic mechanism.
Zein CO; Lopez R; Fu X; Kirwan JP; Yerian LM; McCullough AJ; Hazen SL; Feldstein AE
Hepatology; 2012 Oct; 56(4):1291-9. PubMed ID: 22505276
[TBL] [Abstract][Full Text] [Related]
8. Ectopic and Visceral Fat Deposition in Lean and Obese Patients With Type 2 Diabetes.
Levelt E; Pavlides M; Banerjee R; Mahmod M; Kelly C; Sellwood J; Ariga R; Thomas S; Francis J; Rodgers C; Clarke W; Sabharwal N; Antoniades C; Schneider J; Robson M; Clarke K; Karamitsos T; Rider O; Neubauer S
J Am Coll Cardiol; 2016 Jul; 68(1):53-63. PubMed ID: 27364051
[TBL] [Abstract][Full Text] [Related]
9. Obese Older Type 2 Diabetes Mellitus Patients with Muscle Insulin Resistance Benefit from an Enriched Protein Drink during Combined Lifestyle Intervention: The PROBE Study.
Pasman WJ; Memelink RG; de Vogel-Van den Bosch J; Begieneman MPV; van den Brink WJ; Weijs PJM; Wopereis S
Nutrients; 2020 Sep; 12(10):. PubMed ID: 33003389
[TBL] [Abstract][Full Text] [Related]
10. The Selective Peroxisome Proliferator-Activated Receptor Gamma Modulator CHS-131 Improves Liver Histopathology and Metabolism in a Mouse Model of Obesity and Nonalcoholic Steatohepatitis.
Perakakis N; Joshi A; Peradze N; Stefanakis K; Li G; Feigh M; Veidal SS; Rosen G; Fleming M; Mantzoros CS
Hepatol Commun; 2020 Sep; 4(9):1302-1315. PubMed ID: 32923834
[TBL] [Abstract][Full Text] [Related]
11. The pan-PPAR agonist lanifibranor improves cardiometabolic health in patients with metabolic dysfunction-associated steatohepatitis.
Cooreman MP; Butler J; Giugliano RP; Zannad F; Dzen L; Huot-Marchand P; Baudin M; Beard DR; Junien JL; Broqua P; Abdelmalek MF; Francque SM
Nat Commun; 2024 May; 15(1):3962. PubMed ID: 38730247
[TBL] [Abstract][Full Text] [Related]
12. Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009.
DeFronzo RA
Diabetologia; 2010 Jul; 53(7):1270-87. PubMed ID: 20361178
[TBL] [Abstract][Full Text] [Related]
13. Verification of B-lymphocyte activating factor's involvement in the exacerbation of insulin resistance as well as an autoimmune response in patients with nonalcoholic steatohepatitis and patients with HCV-related chronic liver disease.
Himoto T; Fujita K; Nomura T; Tani J; Morishita A; Yoneyama H; Haba R; Masaki T
Diabetol Metab Syndr; 2017; 9():45. PubMed ID: 28630652
[TBL] [Abstract][Full Text] [Related]
14. Adipose tissue dysfunction increases fatty liver association with pre diabetes and newly diagnosed type 2 diabetes mellitus.
Jorge-Galarza E; Medina-Urrutia A; Posadas-Sánchez R; Posadas-Romero C; Cardoso-Saldaña G; Vargas-Alarcón G; Caracas-Portilla N; González-Salazar C; Torres-Tamayo M; Juárez-Rojas JG
Diabetol Metab Syndr; 2016; 8():73. PubMed ID: 27843495
[TBL] [Abstract][Full Text] [Related]
15. Insulin resistance in the adipose tissue predicts future vascular resistance: The Hiroshima Study on Glucose Metabolism and Cardiovascular Diseases.
Sasaki N; Ueno Y; Ozono R; Nakano Y; Higashi Y
Atherosclerosis; 2024 Apr; 393():117547. PubMed ID: 38703418
[TBL] [Abstract][Full Text] [Related]
16. Signs of Glucagon Resistance After a 2-Week Hypercaloric Diet Intervention.
Suppli MP; Høgedal A; Bagger JI; Chabanova E; van Hall G; Forman JL; Christensen MB; Albrechtsen NJW; Holst JJ; Knop FK
J Clin Endocrinol Metab; 2024 Mar; 109(4):955-967. PubMed ID: 37967235
[TBL] [Abstract][Full Text] [Related]
17. The Effect of Metformin and Standard Therapy versus Standard Therapy alone in Nondiabetic Patients with Insulin Resistance and Nonalcoholic Steatohepatitis (NASH): A Pilot Trial.
Shields WW; Thompson KE; Grice GA; Harrison SA; Coyle WJ
Therap Adv Gastroenterol; 2009 May; 2(3):157-63. PubMed ID: 21180541
[TBL] [Abstract][Full Text] [Related]
18. Extract of a polyherbal formulation ameliorates experimental nonalcoholic steatohepatitis.
Azeemuddin M; Rafiq M; Anturlikar SD; Sharath Kumar LM; Patki PS; Babu UV; Shyam R
J Tradit Complement Med; 2016 Apr; 6(2):160-7. PubMed ID: 27114939
[TBL] [Abstract][Full Text] [Related]
19. Pioglitazone: Indian perspective.
Shukla R; Kalra S
Indian J Endocrinol Metab; 2011 Oct; 15(4):294-7. PubMed ID: 22029000
[TBL] [Abstract][Full Text] [Related]
20. Lupin protein isolate improves insulin sensitivity and steatohepatitis in vivo and modulates the expression of the
Soto-Luna IC; García-López PM; Vargas-Guerrero B; Guzmán TJ; Domínguez-Rosales JA; Gurrola-Díaz CM
Food Sci Nutr; 2021 May; 9(5):2549-2560. PubMed ID: 34026071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
